Actively Recruiting
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Led by Merck Sharp & Dohme LLC · Updated on 2026-04-13
250
Participants Needed
9
Research Sites
188 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Epstein Barr virus (EBV) is a virus which can cause infectious mononucleosis and is associated with certain kinds of cancer and multiple sclerosis. Researchers are looking for new ways to prevent disease related to EBV and have developed a new study vaccine (V350A and V350B). The main goal of this study is to learn about the safety and tolerability of V350A and V350B in healthy adults.
CONDITIONS
Official Title
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be in good health before randomization
- Have a body mass index between 18 and 38 kg/m² for ages 18 to 30
- Have a body mass index between 15 and 38 kg/m² for ages 12 to 17
You will not qualify if you...
- Have had infectious mononucleosis within 12 months before enrollment
- Have any immunosuppressive medical condition or be receiving immunosuppressive therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
California Clinical Trials Medical Group managed by PAREXEL ( Site 0011)
Glendale, California, United States, 91206
Completed
2
QPS-MRA, LLC ( Site 0012)
Miami, Florida, United States, 33143
Active, Not Recruiting
3
Alliance for Multispecialty Research, LLC ( Site 0008)
Kansas City, Missouri, United States, 64114
Actively Recruiting
4
Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0016)
Springfield, Missouri, United States, 65802
Actively Recruiting
5
Velocity Clinical Research Lincoln ( Site 0004)
Lincoln, Nebraska, United States, 68510
Actively Recruiting
6
Velocity Clinical Research, Omaha ( Site 0005)
Omaha, Nebraska, United States, 68134
Active, Not Recruiting
7
Remington-Davis, Inc. ( Site 0017)
Columbus, Ohio, United States, 43215
Actively Recruiting
8
Lynn Health Science Institute ( Site 0010)
Oklahoma City, Oklahoma, United States, 73112
Actively Recruiting
9
Alliance for Multispecialty Research, LLC ( Site 0009)
Knoxville, Tennessee, United States, 37909
Active, Not Recruiting
Research Team
T
Toll Free Number
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
BASIC_SCIENCE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here